ZELTIQ Aesthetics (ZLTQ) Shares are Up 1.69%

ZELTIQ Aesthetics (ZLTQ) : Traders are bullish on ZELTIQ Aesthetics (ZLTQ) as it has outperformed the S&P 500 by a wide margin of 10.42% in the past 4 weeks. The bullishness in the stock continues even in the near-term as the stock has returned an impressive 2.36%, relative to the S&P 500. The stock has continued its bullish performance both in the near-term and the medium-term, as the stock is up 1.69% in the last 1 week, and is up 10.19% in the past 4 weeks. Buying continues as the stock moves higher, suggesting a strong appetite for the stock.

For the current week, the company shares have a recommendation consensus of Buy. The stock has recorded a twenty day Moving Average of 3.22% and the fifty day Moving Average is 16%. ZELTIQ Aesthetics, Inc. is up 33.8% in the last three month period. Year-to-Date the stock performance stands at 31.13%.

ZELTIQ Aesthetics (ZLTQ) : 7 Wall Street analysts covering ZELTIQ Aesthetics (ZLTQ) believe that the average level the stock could reach for the short term is $43.43. The maximum price target given is $48 and the minimum target for short term is around $38, hence the standard deviation is calculated at $4.47.


ZELTIQ Aesthetics (NASDAQ:ZLTQ): stock turned positive on Friday. Though the stock opened at $37.3, the bulls momentum made the stock top out at $37.53 level for the day. The stock recorded a low of $37.03 and closed the trading day at $37.41, in the green by 0.67%. The total traded volume for the day was 218,069. The stock had closed at $37.16 in the previous days trading.

ZELTIQ Aesthetics, Inc. is a medical technology company. The Company is focused on developing and commercializing products utilizing its controlled-cooling technology platform. Its commercial product, the CoolSculpting System, is designed to reduce stubborn fat bulges. The Company sells its CoolSculpting system to dermatologists, plastic surgeons and aesthetic specialists and generates revenue from sales of its CoolSculpting system and from sales of consumables to its customers. Consumables are the CoolSculpting procedure packs that it sells, which are needed to perform procedures using its CoolSculpting system. As of December 31, 2014, it had an installed base of 3,176 CoolSculpting systems installed across approximately 2,688 practices across the world. As of December 31, 2014, 1.5 million CoolSculpting cycles had been shipped to its customers and distributors.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.